A detailed history of State Of Wyoming transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, State Of Wyoming holds 848 shares of EW stock, worth $64,380. This represents 0.01% of its overall portfolio holdings.

Number of Shares
848
Previous 50 1596.0%
Holding current value
$64,380
Previous $4,000 1275.0%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $47,640 - $74,836
798 Added 1596.0%
848 $55,000
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $1,180 - $1,320
14 Added 38.89%
50 $4,000
Q1 2024

May 13, 2024

SELL
$72.54 - $95.56 $92,125 - $121,361
-1,270 Reduced 97.24%
36 $3,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $78,618 - $99,066
1,274 Added 3981.25%
1,306 $99,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $112,995 - $152,302
-1,631 Reduced 98.08%
32 $2,000
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $14,083 - $16,319
-173 Reduced 9.42%
1,663 $156,000
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $61,413 - $69,889
-827 Reduced 31.06%
1,836 $151,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $46,717 - $59,808
684 Added 34.56%
2,663 $198,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $139,370 - $181,534
1,692 Added 589.55%
1,979 $163,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $94,112 - $139,557
-1,088 Reduced 79.13%
287 $27,000
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $4,078 - $5,133
40 Added 3.0%
1,375 $162,000
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $1,382 - $1,698
-13 Reduced 0.96%
1,335 $173,000
Q3 2021

Feb 11, 2022

SELL
$102.91 - $122.75 $19,758 - $23,568
-192 Reduced 12.47%
1,348 $153,000
Q2 2021

Feb 11, 2022

BUY
$83.84 - $104.76 $7,713 - $9,637
92 Added 6.35%
1,540 $159,000
Q1 2021

Feb 08, 2022

BUY
$78.68 - $90.67 $113,928 - $131,290
1,448 New
1,448 $121,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.